|Articles|May 31, 2016
Quintiles Introduces Precision Enrollment Offering
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials.
Advertisement
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials. This new model adjusts the traditional site start-up pathway so that it is only opened after a patient is identified.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
2
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
3
Proactive Planning is Key to Mitigating Study Rescue
4
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
